Summary
The effects of tabernanthine on serotonin (5-HT) levels were determined in several brain areas of rats exposed to various simulated altitudes (1800, 5200, 7000 m). The 5-HT synthesis inhibitor, para-chlorophenylalanine (PCPA), was used to dissociate the effects occurring at synthesis and release levels. Tabernanthine antagonized the decrease in hypothalamic 5-HT levels induced by a 7000 m hypoxia and also suppressed the decrease in PCPA-induced depletion observed at 5200 and 7000 m in the hypothalamus, the striatum and the rest of the brain. It was assumed that tabernanthine stimulates different steps of 5-HT metabolism. These effects, revealed by hypoxia, are related to other peripheral and central properties of this drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boismare F, Le Poncin-Lafitte M, Rapin JR (1980) Blockade of different enzymatic steps in the synthesis of brain amines and memory (CAR) in hypobaric hypoxic rats treated or untreated by l-DOPA. Aviat Space Environ Med 51:126–128
Brown RM, Kehr W, Carlsson A (1975) Functional and biochemical aspects of catecholamine metabolism in brain under hypoxia. Brain Res 85:491–509
Brown RM, Snider SM, Carlsson A (1974) Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. II. The central nervous system. J Neural Transm 35:293–305
Cretet E, Prioux-Guyonneau M, Jacquot C, Sentenac H, Wepierre J (1980) Effect of tabernanthine on the turnover time of brain catecholamines in normal and hypobaric hypoxic rats. Naunyn-Schmiedeberg's Arch Pharmacol 313:119–123
Cruzon G, Green AR (1970) Rapid method for determination of 5-hydroxytryptamine and 5-hydroxyindole-acetic acid in small regions of rat brain. Br J Pharmacol 39:653–655
Curzon G, Kantamaneni BD, Tricklebank MD (1981) A comparison of an improved o-phthalaldehyde fluorimetric method and high pressure liquid chromatography in the determination of brain 5-hydroxyindoles of rats treated with l-tryptophan and p-chlorophenylalanine. Br J Pharmacol 73:555–561
Davis JN, Carlsson A (1973a) Effect of hypoxia on tyrosine and tryptophan hydroxylation in unanesthetized rat brain. J Neurochem 20:913–915
Davis JN, Carlsson A (1973b) The effects of hypoxia on monoamine synthesis level and metabolism in rat brain. J Neurochem 21:783–790
Davis JN, Giron LT, Stanton E, Maury W (1979) The effect of hypoxia on brain neurotransmitter systems. Adv Neurol 26:219–223
Forchetti CM, Meek JL (1981) Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res 206:208–212
Gibson GE, Peterson C, Sansone J (1981) Decrease in amino acid and acetylcholine metabolism during hypoxia. J Neurochem 37:192–201
Hajo H, Dupont Ch, Wepierre J (1981) Action de la tabernanthine sur différents paramètres cardiovasculaires chez le Rat et le Chien. J Pharmacol (Paris) 12:441–454
Hedner T (1978) Central monoamine metabolism and neonate oxygen deprivation. Acta Physiol Scand Suppl 460:34
Iversen LL, Glowinski J (1966) Regional studies of catecholamines in rat brain. J Neurochem 13:655–669
Miller FP, Cox RH, Snodgrass WR, Maickel RP (1970) Comparative effects of p-chlorophenylalanine, p-chloroamphetamine and p-chloro-N-methylamphetamine on rat brain norepinephrine, serotonin and 5-hydroxyindole-3-acetic acid. Biochem Pharmacol 19:435–442
Mocaër-Cretet E (1981) Hypoxie hypobare et neuromédiateurs. Effets pharmacologiques et biochimiques centraux de la tabernanthine. Thesis Pharm: Paris XI, 129:180
Mocaër-Cretet E, Hajo N, Dupont Ch, Jacquot C, Wepierre J (1980): Modification de l'activité comportementale de la tabernanthine chez la Souris en normoxie et en hypoxie hypobare. J Pharmacol (Paris) 11:330
Prioux-Guyonneau M, Cretet E, Jacquot C, Rapin JR, Cohen Y (1979) The effects of various stimulated altitudes of the turnover of norepinephrine and dopamine in the central nervous system of rats. Pflügers Arch 380:127–132
Prioux-Guyonneau M, Mocaër-Cretet E, Redjimi-Hafsi F, Jacquot C (1982) Changes in brain 5-hydroxytryptamine metabolism induced by hypobaric hypoxia. Gen Pharmacol 13:251–254
Raymond-Hamet M, Vincent D (1960) Sur quelques effets pharmacologiques de trois alcaloides du Tabernanthe Iboga Baillon, Ibogamine, Ibolutéine et Tabernanthine. CR Soc Biol 154:2223–2227
Saligaud C, Moore N, Boulu R, Plotkine M, Leclerc JL, Prioux-Guyonneau M, Boismare F (1981) Hypobaric hypoxia: central catecholamines levels, cortical PO2 and avoidance response in rats treated with apomorphine. Aviat Space Environ Med 52:166–170
Scatton B, Ziukovic B, Dedek J, Lloyd KG, Constanti-Dinis J, Tissot R, Bartholini G: γ-aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther 220:678–688
Thomann G, Servin A, Besancon M, Garcet S (1975) Effets d'un complexe alcaloïdique de Vinca minor apocynacées (L.J. 533) sur le comportement et le taux de noradrénaline cérébrale de la souris en hypoxie aiguë. J Pharmacol (Paris) 6:291–300
Valette G, Leclair MF (1977) Effets des alcaloïdes du Tabernanthe Iboga H. Bn. sur les réponses des organes isolés aux catécholamines et rôle des échanges de calcium. Cas de la tabernanthine. C. R. Acad Sci (Paris) 285:591–594
Zetler G (1964) Einige pharmakologische Eigenschaften von 12 natürlichen und 11 partialsynthetisch abgewandelten Indolalkaloiden aus tropischen Apocynaceen des subtribus Tabernaemontaninae. Arzneim Forsch Drug Res 11:1277–1286
Zetler G, Singbartl G, Schlosser L (1972) Cerebral pharmacokinetics of tremor producing harmala and iboga alkaloids. Pharmacology 7:237–248
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mocaër-Cretet, E., Prioux-Guyonneau, M., Redjimi, F. et al. Evidence for an antagonistic action of tabernanthine on hypoxia-induced changes in brain serotonin levels. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 287–290 (1984). https://doi.org/10.1007/BF00501431
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00501431